• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Telomerase Activation in Hematological Malignancies.血液系统恶性肿瘤中的端粒酶激活
Genes (Basel). 2016 Sep 7;7(9):61. doi: 10.3390/genes7090061.
2
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.人类端粒酶逆转录酶(hTERT)基因的转录调控
Genes (Basel). 2016 Aug 18;7(8):50. doi: 10.3390/genes7080050.
3
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.端粒酶hTERT基因的转录调控作为细胞和病毒致癌机制的一个靶点。
Carcinogenesis. 2003 Jul;24(7):1167-76. doi: 10.1093/carcin/bgg085. Epub 2003 May 22.
4
Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.通过宿主细胞募集实现组织形成和组织工程,或具有复制潜力的潜在可注射细胞基生物复合材料:控制细胞衰老的分子机制以及可控瞬时端粒酶激活疗法的参与。
J Biomed Mater Res A. 2015 Dec;103(12):3993-4023. doi: 10.1002/jbm.a.35515. Epub 2015 Aug 14.
5
Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.人类发育过程中的端粒酶活性受人类端粒酶逆转录酶(hTERT)转录以及hTERT转录本的可变剪接调控。
Cancer Res. 1998 Sep 15;58(18):4168-72.
6
Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.通过表达显性负性hTERT突变体抑制端粒酶后,人白血病细胞系中的端粒功能障碍和端粒酶重新激活。
Oncogene. 2002 Nov 28;21(54):8262-71. doi: 10.1038/sj.onc.1206054.
7
Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.人端粒酶逆转录酶在人肺癌细胞中的表达及可变剪接模式
Int J Oncol. 2004 Apr;24(4):925-30.
8
Human Specific Regulation of the Telomerase Reverse Transcriptase Gene.人类端粒酶逆转录酶基因的特异性调控。
Genes (Basel). 2016 Jun 28;7(7):30. doi: 10.3390/genes7070030.
9
Physiological and pathological significance of human telomerase reverse transcriptase splice variants.人类端粒酶逆转录酶剪接变异体的生理和病理意义。
Biochimie. 2013 Nov;95(11):1965-70. doi: 10.1016/j.biochi.2013.07.031. Epub 2013 Aug 9.
10
Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.端粒替代延长细胞中端粒酶基因表达的缺失与hTR和hTERT基因启动子的染色质重塑相关。
Cancer Res. 2005 Sep 1;65(17):7585-90. doi: 10.1158/0008-5472.CAN-05-1715.

引用本文的文献

1
The Telomere Length Signature in Leukemias-From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase.白血病中的端粒长度特征——从端粒缩短的分子机制到针对端粒酶的免疫治疗选择
Cancers (Basel). 2025 Jun 10;17(12):1936. doi: 10.3390/cancers17121936.
2
Exploiting the Achilles' heel of cancer through a structure-based drug-repurposing approach and experimental validation of top drugs using the TRAP assay.通过基于结构的药物重新利用方法利用癌症的阿喀琉斯之踵,并使用TRAP测定法对顶级药物进行实验验证。
Mol Divers. 2025 Mar 14. doi: 10.1007/s11030-025-11162-1.
3
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.经工程改造的人树突状细胞诱导的细胞毒性淋巴细胞介导强大的抗白血病活性。
Cancer Immunol Immunother. 2025 Feb 25;74(4):117. doi: 10.1007/s00262-025-03971-y.
4
Associations between , 1 Gene Polymorphisms and Relative Leukocyte Telomere Length with Myopia and Its Degree.1基因多态性与相对白细胞端粒长度与近视及其程度之间的关联。 (注:原文中“Associations between, 1 Gene Polymorphisms”表述不太准确规范,可能存在信息缺失或错误,但按照要求进行了翻译)
Biomedicines. 2024 Feb 28;12(3):538. doi: 10.3390/biomedicines12030538.
5
Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma.端粒长度和 hTERT 基因变异作为多发性骨髓瘤潜在的预后标志物。
Sci Rep. 2023 Sep 22;13(1):15792. doi: 10.1038/s41598-023-43141-7.
6
Spotlight on Complex Regulation in Cutaneous T-Cell Lymphomas.聚焦皮肤 T 细胞淋巴瘤中的复杂调控。
Genes (Basel). 2023 Feb 8;14(2):439. doi: 10.3390/genes14020439.
7
Methylation of Subtelomeric Chromatin Modifies the Expression of the lncRNA TERRA, Disturbing Telomere Homeostasis.端粒外染色质甲基化修饰 lncRNA TERRA 的表达,扰乱端粒稳态。
Int J Mol Sci. 2022 Mar 18;23(6):3271. doi: 10.3390/ijms23063271.
8
TERT rs2853669 as a predictor for overall survival in patients with acute myeloid leukaemia.端粒酶逆转录酶基因 rs2853669 作为急性髓系白血病患者总生存的预测指标
Arch Med Sci. 2021 Mar 18;18(1):103-111. doi: 10.5114/aoms/100673. eCollection 2022.
9
Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.探索皮肤 T 细胞淋巴瘤中的端粒酶逆转录酶启动子甲基化。
Mol Oncol. 2022 May;16(9):1931-1946. doi: 10.1002/1878-0261.12946. Epub 2021 Oct 12.
10
Telomere Length and Hematological Disorders: A Review.端粒长度与血液系统疾病:综述
In Vivo. 2020 Nov-Dec;34(6):3093-3101. doi: 10.21873/invivo.12142.

本文引用的文献

1
Telomerase in hematologic malignancies.血液系统恶性肿瘤中的端粒酶
Curr Opin Hematol. 2016 Jul;23(4):346-53. doi: 10.1097/MOH.0000000000000252.
2
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.端粒酶逆转录酶(TERT)启动子突变在胶质母细胞瘤中的预后影响因单核苷酸多态性rs2853669而改变。
Int J Cancer. 2016 Jul 15;139(2):414-23. doi: 10.1002/ijc.30057. Epub 2016 Mar 24.
3
Reactivation of telomerase in cancer.癌症中端粒酶的重新激活。
Cell Mol Life Sci. 2016 Apr;73(8):1659-70. doi: 10.1007/s00018-016-2146-9. Epub 2016 Feb 4.
4
Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.多种途径控制人嗜T淋巴细胞病毒I型相关白血病中端粒酶的重新激活。
Int J Cancer Oncol. 2015 Jun 2;2(2). doi: 10.15436/2377-0902.15.017.
5
DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension.癌症治疗中的 DNA 甲基化抑制剂:免疫维度。
Cell. 2015 Aug 27;162(5):938-9. doi: 10.1016/j.cell.2015.08.005.
6
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.端粒酶逆转录酶(TERT)启动子多态性与急性髓系白血病风险及预后之间的关联。
Oncotarget. 2015 Sep 22;6(28):25109-20. doi: 10.18632/oncotarget.4668.
7
Therapeutic targeting of replicative immortality.对复制性永生的治疗靶向
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S104-S128. doi: 10.1016/j.semcancer.2015.03.007. Epub 2015 Apr 11.
8
Role of the functional MNS16A VNTR-243 variant of the human telomerase reverse transcriptase gene in progression and response to therapy of patients with non-Hodgkin's B-cell lymphomas.人类端粒酶逆转录酶基因功能性MNS16A VNTR-243变异体在非霍奇金B细胞淋巴瘤患者病情进展及治疗反应中的作用
Int J Immunogenet. 2015 Apr;42(2):100-5. doi: 10.1111/iji.12182. Epub 2015 Feb 12.
9
Histone deacetylase inhibitors in hematological malignancies and solid tumors.血液系统恶性肿瘤和实体瘤中的组蛋白去乙酰化酶抑制剂
Arch Pharm Res. 2015 Jun;38(6):933-49. doi: 10.1007/s12272-015-0571-1. Epub 2015 Feb 5.
10
Bone marrow failure and the telomeropathies.骨髓衰竭与端粒病。
Blood. 2014 Oct 30;124(18):2775-83. doi: 10.1182/blood-2014-05-526285. Epub 2014 Sep 18.

血液系统恶性肿瘤中的端粒酶激活

Telomerase Activation in Hematological Malignancies.

作者信息

Ropio Joana, Merlio Jean-Philippe, Soares Paula, Chevret Edith

机构信息

Cutaneous Lymphoma Oncogenesis Team INSERM U1053 Bordeaux Research in Translational Oncology, Bordeaux University, Bordeaux 33076, France.

Institute of Biomedical Sciences of Abel Salazar, University of Porto, Porto 4050-313, Portugal.

出版信息

Genes (Basel). 2016 Sep 7;7(9):61. doi: 10.3390/genes7090061.

DOI:10.3390/genes7090061
PMID:27618103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5039560/
Abstract

Telomerase expression and telomere maintenance are critical for cell proliferation and survival, and they play important roles in development and cancer, including hematological malignancies. Transcriptional regulation of the rate-limiting subunit of human telomerase reverse transcriptase gen (hTERT) is a complex process, and unveiling the mechanisms behind its reactivation is an important step for the development of diagnostic and therapeutic applications. Here, we review the main mechanisms of telomerase activation and the associated hematologic malignancies.

摘要

端粒酶表达和端粒维持对于细胞增殖和存活至关重要,并且它们在发育和癌症(包括血液系统恶性肿瘤)中发挥重要作用。人端粒酶逆转录酶基因(hTERT)限速亚基的转录调控是一个复杂的过程,揭示其重新激活背后的机制是开发诊断和治疗应用的重要一步。在此,我们综述端粒酶激活的主要机制及相关的血液系统恶性肿瘤。